Astrana Health, Inc. (NASDAQ: ASTH) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $1.6B. The Maz Rating grades it against the other companies in its sector.
Astrana Health, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $31.99, Astrana Health, Inc. trades at 29.5x trailing earnings, 0.4x sales and 1.8x book value, with an EV/EBITDA of 10.1. Over the last twelve months it generated about $3.9B of revenue and $54M of net income. It runs a gross margin of 10.1%, an operating margin of 3.1% and a net margin of 1.4%. It shows return on equity of 6.5%, return on invested capital of 5.0% and a free cash flow yield of 10.3%. On the balance sheet: a debt-to-equity ratio of 1.14 and a current ratio of 1.25. Over the past 52 weeks the share price ranged from $18.08 to $51.60, with a beta of 0.91.
Astrana Health, Inc. does not currently pay a dividend.
11 Wall Street analyst ratings cover the stock: 11 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.